Previous findings indicate that the noradrenergic, dopaminergic, and cholinergic innervations of the basolateral amygdala (BLA) modulate memory consolidation. The current study investigated whether memory enhancement induced by post-training intra-BLA infusions of a -adrenergic or muscarinic cholinergic agonist requires concurrent activation of dopamine (DA) receptors in the BLA. Rats with implanted BLA cannulae were trained on an inhibitory avoidance (IA) task and, 48 h later, tested for retention. Infusions of the -adrenergic agonist clenbuterol into the right BLA, but not the left, enhanced retention, and concurrent infusions of the nonspecific DA receptor antagonist cis-Flupenthixol (Flu) blocked the enhancement. Post-training infusions of the muscarinic agonist oxotremorine into the right BLA also enhanced retention, and concurrent infusions of Flu blocked this effect. Additional experiments investigated whether memory modulation was lateralized to the right BLA. Post-training DA infusions into the right BLA, but not the left, enhanced retention. Post-training infusions of lidocaine or muscimol, which impair retention when infused bilaterally, had no effect when infused unilaterally into either the right or left BLA. These findings, together with earlier work, suggest that the dopaminergic system in the BLA is critically involved in memory modulation induced by noradrenergic and cholinergic influences. Additionally, these findings indicate that the enhancement, but not impairment, of memory consolidation is lateralized to the right BLA.Considerable evidence indicates that the dopaminergic, noradrenergic, and muscarinic cholinergic systems in the basolateral amygdala (BLA) play important roles modulating memory consolidation. Post-training intra-BLA infusions of noradrenergic agonists, norepinephrine, dopamine (DA), or muscarinic cholinergic agonists enhance retention of training in a variety of tasks (Introini-Collison et al. 1996;Hatfield and McGaugh 1999;LaLumiere et al. 2003LaLumiere et al. , 2004Power et al. 2003a;McGaugh 2004). Moreover, these systems are critical for memory modulation induced by other neurotransmitters or hormones. Post-training intra-BLA infusions of -adrenoceptor antagonists block the memory-enhancing effects of opioid-peptidergic antagonists, glucocorticoid agonists, and DA (McGaugh et al. 1988;Quirarte et al. 1997;LaLumiere et al. 2004). Similarly, post-training intra-BLA infusions of muscarinic cholinergic antagonists block the memory-enhancing effects of glucocorticoid agonists, -adrenergic agonists, and DA (Introini-Collison et al. 1996;Power et al. 2000;LaLumiere et al. 2004).Studies of the effects of DA receptor antagonists provide additional evidence suggesting that the dopaminergic system in the BLA is also critically involved in memory modulation. Post-training intra-BLA infusions of a D1 or D2 receptor antagonist impair retention for inhibitory avoidance (IA) training (LaLumiere et al. 2004), and post-training intra-BLA infusions of the nonspecific DA receptor antagon...